196 related articles for article (PubMed ID: 22853316)
1. The GATA1s isoform is normally down-regulated during terminal haematopoietic differentiation and over-expression leads to failure to repress MYB, CCND2 and SKI during erythroid differentiation of K562 cells.
Halsey C; Docherty M; McNeill M; Gilchrist D; Le Brocq M; Gibson B; Graham G
J Hematol Oncol; 2012 Aug; 5():45. PubMed ID: 22853316
[TBL] [Abstract][Full Text] [Related]
2. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
[TBL] [Abstract][Full Text] [Related]
4. miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH; Li Z; Böhmer K; Maroz A; Koch ML; Emmrich S; Godinho FJ; Orkin SH; Reinhardt D
Genes Dev; 2010 Mar; 24(5):478-90. PubMed ID: 20194440
[TBL] [Abstract][Full Text] [Related]
5. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
Chlon TM; McNulty M; Goldenson B; Rosinski A; Crispino JD
Haematologica; 2015 May; 100(5):575-84. PubMed ID: 25682601
[TBL] [Abstract][Full Text] [Related]
6. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G; Sakakini N; Chagraoui H; Cruz Hernandez D; Cheng Q; Soady K; Stoilova B; Garnett C; Waithe D; Otto G; Doondeea J; Usukhbayar B; Karkoulia E; Alexiou M; Strouboulis J; Morrissey E; Roberts I; Porcher C; Vyas P
Haematologica; 2021 Apr; 106(4):1106-1119. PubMed ID: 32527952
[TBL] [Abstract][Full Text] [Related]
8. The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice.
Ishihara D; Hasegawa A; Hirano I; Engel JD; Yamamoto M; Shimizu R
Exp Hematol Oncol; 2024 Feb; 13(1):24. PubMed ID: 38409186
[TBL] [Abstract][Full Text] [Related]
9. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
Garnett C; Cruz Hernandez D; Vyas P
IUBMB Life; 2020 Jan; 72(1):119-130. PubMed ID: 31769932
[TBL] [Abstract][Full Text] [Related]
10. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP; Subramanian A; Langebrake C; Reinhardt D; Bernard O; Ballerini P; Baruchel A; Cavé H; Dastugue N; Hasle H; Kaspers GL; Lessard M; Michaux L; Vyas P; van Wering E; Zwaan CM; Golub TR; Orkin SH
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3339-44. PubMed ID: 16492768
[TBL] [Abstract][Full Text] [Related]
11. The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis.
Alejo-Valle O; Weigert K; Bhayadia R; Ng M; Issa H; Beyer C; Emmrich S; Schuschel K; Ihling C; Sinz A; Zimmermann M; Wickenhauser C; Flasinski M; Regenyi E; Labuhn M; Reinhardt D; Yaspo ML; Heckl D; Klusmann JH
Blood; 2022 Feb; 139(5):651-665. PubMed ID: 34570885
[TBL] [Abstract][Full Text] [Related]
12. Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation.
Manavathi B; Lo D; Bugide S; Dey O; Imren S; Weiss MJ; Humphries RK
J Biol Chem; 2012 Feb; 287(8):5600-14. PubMed ID: 22187427
[TBL] [Abstract][Full Text] [Related]
13. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
Sit YT; Takasaki K; An HH; Xiao Y; Hurtz C; Gearhart PA; Zhang Z; Gadue P; French DL; Chou ST
JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906251
[TBL] [Abstract][Full Text] [Related]
14. Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model.
Arkoun B; Robert E; Boudia F; Mazzi S; Dufour V; Siret A; Mammasse Y; Aid Z; Vieira M; Imanci A; Aglave M; Cambot M; Petermann R; Souquere S; Rameau P; Catelain C; Diot R; Tachdjian G; Hermine O; Droin N; Debili N; Plo I; Malinge S; Soler E; Raslova H; Mercher T; Vainchenker W
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35587378
[TBL] [Abstract][Full Text] [Related]
15. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome-related myeloid disorders.
Kanezaki R; Toki T; Terui K; Sato T; Kobayashi A; Kudo K; Kamio T; Sasaki S; Kawaguchi K; Watanabe K; Ito E
Sci Rep; 2022 Nov; 12(1):20587. PubMed ID: 36447001
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham L; Vendramini E; Ge Y; Goren Y; Birger Y; Tijssen MR; McNulty M; Geron I; Schwartzman O; Goldberg L; Chou ST; Pitman H; Weiss MJ; Michaeli S; Sredni B; Göttgens B; Crispino JD; Taub JW; Izraeli S
Blood; 2015 Feb; 125(8):1292-301. PubMed ID: 25533034
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.
Ge Y; Dombkowski AA; LaFiura KM; Tatman D; Yedidi RS; Stout ML; Buck SA; Massey G; Becton DL; Weinstein HJ; Ravindranath Y; Matherly LH; Taub JW
Blood; 2006 Feb; 107(4):1570-81. PubMed ID: 16249385
[TBL] [Abstract][Full Text] [Related]
19. GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
Maroz A; Stachorski L; Emmrich S; Reinhardt K; Xu J; Shao Z; Käbler S; Dertmann T; Hitzler J; Roberts I; Vyas P; Juban G; Hennig C; Hansen G; Li Z; Orkin S; Reinhardt D; Klusmann JH
Leukemia; 2014 Jun; 28(6):1259-70. PubMed ID: 24336126
[TBL] [Abstract][Full Text] [Related]
20. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.
Matsumura I; Kawasaki A; Tanaka H; Sonoyama J; Ezoe S; Minegishi N; Nakajima K; Yamamoto M; Kanakura Y
Blood; 2000 Oct; 96(7):2440-50. PubMed ID: 11001896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
